Recent developments in latency and recombination of Aujeszky's disease (pseudorabies) virus.
Latency is a characteristic and fascinating part of the biology of alphaherpesvirinae, including ADV. Tissue explanation, blot hybridization, in situ hybridization and more recently PCR are the experimental methods used to demonstrate that latent infections consistently occur in ganglionic neurons and, at a lower level, in tonsillar and possibly other cells. In vivo reactivation of ADV, resulting in shedding of virulent ADV, has been demonstrated experimentally following administration of high doses of corticosteriods. To determine the influence of vaccination with currently used gene deleted vaccines on field virus latency load, it is essential to use quantitative latency detection methods. We have developed chemiluminescence-based quantitative PCR assays specific for gG and gE, and are currently using these to determine field virus latency loads in tissues of pigs vaccinated with one of several gene deleted vaccines. Recombination between ADV strains has been demonstrated both in vitro and in vivo and has raised concerns about the generation of gene deleted virulent ADV strains. Recent studies in a mouse model have shown that high concentrations of both strains have to be present at the same anatomical site for recombination to take place. This led to the conclusion that ongoing ADV eradication programs, based upon the use of gene deleted vaccines and differential serological testing, are not likely to be threatened by recombination between virulent ADV and gene deleted vaccine strains.
Maes
R K
RK
Dept. of Microbiology, College of Veterinary Medicine, Michigan State University, E. Lansing 48824, USA.
Sussman
M D
MD
Vilnis
A
A
Thacker
B J
BJ
D000818:Animals; D017353:Gene Deletion; D011558:Herpesvirus 1, Suid / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D008221:Lymphoid Tissue / Q000821:virology; D051379:Mice; D009474:Neurons / Q000821:virology; D016133:Polymerase Chain Reaction; D011557:Pseudorabies / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology*; D022421:Pseudorabies Vaccines; D011995:Recombination, Genetic; D013552:Swine; D014158:Transcription, Genetic; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; D014774:Virulence; D014775:Virus Activation; D017735:Virus Latency; D017201:Virus Shedding
D022421:Pseudorabies Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines